Alembic Pharmaceuticals Limited (BOM:533573)
818.10
-8.10 (-0.98%)
At close: Feb 14, 2025
Alembic Pharmaceuticals Employees
Alembic Pharmaceuticals had 14,858 employees as of March 31, 2024. The number of employees increased by 265 or 1.82% compared to the previous year.
Employees
14,858
Change (1Y)
265
Growth (1Y)
1.82%
Revenue / Employee
4.32M INR
Profits / Employee
407.01K INR
Market Cap
157.92B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Reliance Industries | 347,362 |
Tata Consultancy Services | 601,546 |
HDFC Bank | 213,527 |
Bharti Airtel | 23,628 |
ICICI Bank | 187,765 |
Infosys | 317,240 |
State Bank of India | 232,296 |
Hindustan Unilever | 19,427 |
Alembic Pharmaceuticals News
- 6 days ago - Stocks to watch today: M&M, BHEL, Zydus Life, Alembic Pharma, and PCBL in focus on Feb 17, 2025 - Business Upturn
- 5 weeks ago - Alembic Pharmaceuticals receives USFDA approval for Brexpiprazole tablets - Business Upturn
- 2 months ago - Alembic Pharmaceuticals shares surge nearly 3% on USFDA approval for Divalproex Sodium Capsules - Business Upturn
- 2 months ago - Alembic Pharmaceuticals secures USFDA approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg - Business Upturn
- 2 months ago - Alembic Pharmaceuticals completes ANVISA GMP Audit for API-II Facility in Brazil - Business Upturn
- 2 months ago - Alembic Pharmaceuticals receives tentative USFDA approval for olopatadine hydrochloride solution - Business Upturn
- 3 months ago - Alembic Pharma shares surged nearly 5% today - Business Upturn
- 3 months ago - Alembic Pharmaceuticals secures USFDA approval for Ivabradine tablets - Business Upturn